Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy. However, so far, only a handful of nanoparticle-based cancer drugs have been FDA-approved.
Click here for original story, How different cancer cells respond to drug-delivering nanoparticles
Source: Phys.org